Inventor · disambiguated record
Donald J. Buchsbaum
Also filed as: BUCHSBAUM DONALD · BUCHSBAUM DONALD J · BUCHSBAUM DONALD JAY
18 granted patents·13 pending applications·289 citations·filing 1993–2019
94Inventor score
Files withUAB RESEARCH FOUNDATION14BUCHSBAUM DONALD J5UAB RES FOUND2VARLEY KATHERINE E2HUDSONALPHA INST FOR BIOTECHNOLOGY1
Top patents by PatentIndex Score
31 records- 0191US6001329ARadiolabeled fusion toxins for cancer therapyUAB RESEARCH FOUNDATION·Filed 1997·Granted Dec 14, 1999·91 cites·11 claims
- 0290US7704502B2Combinations of antibodies selective for DR5 and other therapeutic agentsUAB RESEARCH FOUNDATION·Filed 2007·Granted Apr 27, 2010·14 cites·70 claims
- 0389US7981421B2Combinations of antibodies selective for DR5 and other therapeutic agentsUAB RESEARCH FOUNDATION·Filed 2010·Granted Jul 19, 2011·13 cites·58 claims
- 0486US7279160B2Combinations of DR5 antibodies and other therapeutic agentsUAB RESEARCH FOUNDATION·Filed 2002·Granted Oct 9, 2007·24 cites·65 claims
- 0585US6552005B1Molecular chemotherapy enhancement of radiotherapyUAB RESEARCH FOUNDATION·Filed 2000·Granted Apr 22, 2003·27 cites·14 claims
- 0681US7476383B2Antibody selective for DR4 and uses thereofUAB RESEARCH FOUNDATION·Filed 2002·Granted Jan 13, 2009·9 cites·54 claims
- 0772US6468547B1Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain secretory antibodiesUAB RESEARCH FOUNDATION·Filed 2000·Granted Oct 22, 2002·2 cites·9 claims
- 0871US8703712B2Targeting cancer stem cells with DR5 agonistsBUCHSBAUM DONALD J·Filed 2011·Granted Apr 22, 2014·4 cites·6 claims
- 0969US5902583AGenetic induction of receptors for targeted radiotherapyUAB RESEARCH FOUNDATION·Filed 1997·Granted May 11, 1999·40 cites·22 claims
- 1068US2009208483A1Antibody selective for dr4 and uses thereofUAB RESEARCH FOUNDATION·Filed 2008·Application pending·0 cites
- 1167US9527915B2Treating basal-like genotype cancersBUCHSBAUM DONALD J·Filed 2010·Granted Dec 27, 2016·1 cites·13 claims
- 1266US12157759B2Method of treating breast cancerHUDSONALPHA INST FOR BIOTECHNOLOGY·Filed 2019·Granted Dec 3, 2024·0 cites·16 claims
- 1362US6703375B2Molecular chemotherapy enhancement of radiotherapyUAB RESEARCH FOUNDATION·Filed 2002·Granted Mar 9, 2004·6 cites·25 claims
- 1460US6074640AEnhancement of tumor cell radiosensitivity using single chain intracellular antibodiesUAB RESEARCH FOUNDATION·Filed 1997·Granted Jun 13, 2000·12 cites·19 claims
- 1558US5756825AHydroxamic acid-based bifunctional chelating compoundsFiled 1993·Granted May 26, 1998·29 cites·4 claims
- 1657US2005281814A1Combination radiation therapy and chemotherapy in conjunction with administration of growth factor receptor antibodyBUCHSBAUM DONALD J·Filed 2005·Application pending·0 cites
- 1753US2002076408A1Combination radiation therapy and chemotherapy in conjunction with administration of growth factor receptor antibodyFiled 2001·Application pending·0 cites
- 1851US10316100B2Treating basal-like genotype cancersUAB RES FOUND·Filed 2016·Granted Jun 11, 2019·0 cites·3 claims
- 1951US2009297509A1Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinasesIMCLONE SYSTEMS INC·Filed 2009·Application pending·0 cites
- 2051US2017267733A1Novel Read-Through Fusion Polynucleotides and Polypeptides and Uses ThereofVARLEY KATHERINE E·Filed 2016·Application pending·0 cites
- 2149US2014162296A1Novel Read-Through Fusion Polynucleotides and Polypeptides and Uses ThereofVARLEY KATHERINE E·Filed 2013·Application pending·0 cites
- 2248US9637543B2HER3 antibodies and uses thereofUAB RES FOUND·Filed 2012·Granted May 2, 2017·0 cites·17 claims
- 2347US2008132417A1Molecular Basis For The Identification Of Chemotherapy Resistance In Human Tumors And The Treatment ThereofUAB RESEARCH FOUNDATION·Filed 2005·Application pending·0 cites
- 2446US2004057950A1Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinasesFiled 2003·Application pending·0 cites
- 2546US2002048550A1Radiolabeled immunotoxinsFiled 2001·Application pending·0 cites
- 2645US5981504AGenetic induction of receptors for targeted radiotherapyUAB RESEARCH FOUNDATION·Filed 1997·Granted Nov 9, 1999·11 cites·26 claims
- 2745US2007148710A1Cpt resistant cell lineBUCHSBAUM DONALD J·Filed 2004·Application pending·0 cites
- 2842US2007225245A1Viral vector driven mutant bacterial cytosine deaminase gene and uses thereofBUCHSBAUM DONALD J·Filed 2007·Application pending·0 cites
- 2937US6599909B1Molecular chemotherapy enhancement of radiotherapyUAB RESEARCH FOUNDATION·Filed 1999·Granted Jul 29, 2003·6 cites·7 claims
- 3036US2011293515A1Heterofunctional segment-poly (ethylene glycol) polymers as delivery vehiclesSAFAVY AHMAD·Filed 2010·Application pending·0 cites
- 3135US2017210741A1Benzimidazole Compounds, Use As Inhibitors of WNT Signaling Pathway in Cancers, and Methods for Preparation ThereofSOUTHERN RES INST·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Donald J. Buchsbaum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →